Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Recurrent Squamous Cell Carcinoma of the Head or Neck”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 7 of 0 results

Testing effectiveness (Phase 2)WithdrawnNCT05743270
What this trial is testing

Study of RP3 in Combination With Nivolumab and Other Therapy in Patients With Locoregionally Advanced or Recurrent SCCHN

Who this might be right for
Squamous Cell Carcinoma of Head and NeckLocally Advanced Head and Neck Squamous Cell CarcinomaRecurrent Head and Neck Squamous Cell Carcinoma
Replimune, Inc.
Early research (Phase 1)Study completedNCT02262741
What this trial is testing

A Phase I Study to Evaluate the Safety, Tolerability and Efficacy of MEDI4736 (Durvalumab) With Tremelimumab in Head and Neck Cancer

Who this might be right for
Squamous Cell Carcinoma of the Head and Neck
MedImmune LLC 71
Testing effectiveness (Phase 2)Study completedNCT00281866
What this trial is testing

Erlotinib in Treating Patients With Metastatic and/or Recurrent Head and Neck Cancer

Who this might be right for
Head and Neck Cancer
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 37
Early research (Phase 1)Study completedNCT00031681
What this trial is testing

7-Hydroxystaurosporine and Irinotecan Hydrochloride in Treating Patients With Metastatic or Unresectable Solid Tumors or Triple Negative Breast Cancer (Currently Accruing Only Triple-negative Breast Cancer Patients Since 6/8/2007)

Who this might be right for
Advanced Adult Primary Liver CancerCarcinoma of the AppendixEstrogen Receptor-negative Breast Cancer+85 more
National Cancer Institute (NCI) 41
Early research (Phase 1)Study completedNCT03198130
What this trial is testing

An Exploratory Tumor Biopsy-driven Study to Understand the Relationship Between Biomarkers and Clinical Response in Patients With Head and Neck Cancer Receiving REGN2810 (Anti-PD-1)

Who this might be right for
Recurrent Squamous Cell Carcinoma of HeadRecurrent Squamous Cell Carcinoma of NeckMetastatic Squamous Cell Carcinoma of Head+1 more
Regeneron Pharmaceuticals 33
Testing effectiveness (Phase 2)Ended earlyNCT02524275
What this trial is testing

Docetaxel and Capecitabine With Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck

Who this might be right for
Head and Neck Squamous Cell Carcinoma
University of Nebraska 14
Large-scale testing (Phase 3)Study completedNCT04338399
What this trial is testing

The BURAN Study of Buparlisib in Patients With Recurrent or Metastatic HNSCC

Who this might be right for
Head and Neck Cancer
Adlai Nortye Biopharma Co., Ltd. 487